Open Nav

Aural Analytics, Inc.

  • Daniel Jones, Aural Analytics, Inc.

Generate awareness and interest in our funding round, industry impact, and validation data.

  • Date:Wednesday, October 17
  • Time:3:30 PM - 3:45 PM
  • Room:Elizabethan C
  • Location:2nd Floor
  • Session Type:Company Presentation
  • Presentation Type:Privately Funded Company
  • Company Description/Mission Statement:Bringing together decades of research on neurological diseases, artificial intelligence (AI), neuroscience, speech analytics, speech pathology, and mobile software platforms for health monitoring, Aural Analytics has built proprietary metrics that use speech to capture changes in neurological health. Aural Analytics builds custom applications focused on early detection, longitudinal tracking, patient stratification, precise/objective measures, and eventually diagnosis of neurological disease. This technology has been deployed on 4 continents, 6 languages, is device, location, language, disease agnostic and was the recipient of the 2017 Global SCRIP Award for Best Technology Development. The company has been funded by NSF, NIH and has several customers using the technology in market today.
  • Company
  • Company HQ City:Scottsdale
  • Company HQ Country:United States
  • Company HQ State:Arizona                        
  • CEO/Top Company Official:Daniel J. Jones
  • Year Founded:2015
  • Main Therapeutic Focus:CNS/Neurological
  • Lead Product in Development :SpeechAssess
  • Development Phase of Primary Product:Multiple Products in Market
  • Previous and Current Investors:N/A
  • Size of Last Investment Round:N/A
  • Total Amount Raised to Date, In All Rounds:N/A - funded entirely by grants and revenues to date
Daniel Jones
Aural Analytics, Inc.